Viveve Medical (VIVE) 8-K Entry into a Material Definitive Agreement

Exhibit 99.1

Viveve Medical, Inc.

342 Inverness Drive South,

Building B, Suite 250

Englewood, Colorado 80112

April 15, 2020

VStock Transfer, LLC

18 Lafayette Place

Woodmere, New York 11598

Attn: Young D. Kim, Esq.

Re: Viveve Medical, Inc. Series A Warrants (CUSIP: 92852W 121) and Series B warrants (CUSIP: 92852W 113)

Ladies and Gentlemen:

Please be advised that, effective April 15, 2020, pursuant to Section 3(g) of the Series A Common Stock Purchase Warrants of Viveve Medical, Inc. (the “Series A Warrants”) and Section 3(g) of the Series B Common Stock Purchase Warrant of Viveve Medical, Inc. (the “Series B Warrants”), the Exercise Price for the outstanding Series A Warrants and the Series B Warrants has been adjusted to $0.61 per share of common stock, par value $0.0001 per share (CUSIP 92852W204) (“Common Stock”). 

Sincerely,
VIVEVE MEDICAL, INC.
By:	/s/ Scott Durbin
	Scott Durbin
	Chief Executive Officer